[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100555915":3},{"organization":4,"armGroups":7,"interventions":18,"overallOfficials":11,"centralContacts":11,"locations":11,"responsibleParty":28,"collaborators":11,"id":32,"slug":33,"hasResults":34,"nctId":35,"briefTitle":36,"officialTitle":36,"acronym":11,"eligibilityCriteria":37,"healthyVolunteers":38,"sex":39,"minAge":40,"maxAge":41,"enrollmentInfo":42,"targetDuration":11,"studyType":45,"phases":46,"briefSummary":48,"conditions":49,"keywords":11,"overallStatus":51,"whyStopped":11,"lastUpdateSubmitDate":52,"lastUpdatePostDateStruct":53,"startDateStruct":56,"completionDateStruct":58,"leadSponsor":60,"locationsCount":11},{"fullName":5,"class":6},"Shalamar Institute of Health Sciences","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"nitrofurantoin group","ACTIVE_COMPARATOR",null,[13],"Drug: Nitrofurantoin 100 MG",{"label":15,"type":10,"description":11,"interventionNames":16},"Fosfomycin group",[17],"Drug: Fosfomycin",[19,24],{"type":20,"name":21,"description":22,"armGroupLabels":23,"otherNames":11},"DRUG","Nitrofurantoin 100 MG","Comparing two drugs in UTI treatment",[9],{"type":20,"name":25,"description":26,"armGroupLabels":27,"otherNames":11},"Fosfomycin","treatment of UTI",[15],{"type":29,"investigatorFullName":30,"investigatorTitle":31,"investigatorAffiliation":5,"oldNameTitle":11,"oldOrganization":11},"PRINCIPAL_INVESTIGATOR","Sheema Yousuf","Doctor","100555915","phase-4-comparison-of-nitrofurantoin-with-fosfomycin-in-treating-cystitis-in-women-100555915",false,"NCT06518291","COMPARISON OF NITROFURANTOIN WITH FOSFOMYCIN in TREATING CYSTITIS IN WOMEN","Inclusion Criteria:\n\n* Adult women aged 18 years and older presenting with at least 1 symptom of lower UTI such as dysuria, urgency, frequency, or suprapubic tenderness and a urine dipstick test result positive for either nitrites or leukocyte esterase. Confirmed UTI will require the presence of at least 1 of the 4 urinary symptoms required for inclusion and a positive urine culture (≥103 cfu\u002FmL). 21\n\nExclusion Criteria:\n\n* 1\\) Pregnancy and lactation 2) Suspected upper UTI (presence of fever, chills, or flank pain) 3) Antibiotic use or any symptoms consistent with UTI in the preceding 4 weeks 4) Indwelling urinary catheter or otherwise complicated UTI 5) Immunosuppression (untreated infection with HIV, ongoing chemotherapy or radiation therapy, use of high-dose corticosteroids or other immunosuppressive medication) 6) Renal insufficiency (creatinine clearance \\\u003C30 mL\u002Fmin).",true,"FEMALE","18 Years","83 Years",{"count":43,"type":44},392,"ESTIMATED","INTERVENTIONAL",[47],"PHASE4","Fosfomycin and nitrofurantoin are increasingly being prescribed in outpatients for the oral treatment of urinary tract infection (UTI). The newest guidelines for empirical treatment of women with uncomplicated urinary tract infections (UTIs) advise clinicians to choose among three venerable antibiotics: trimethoprim-sulfamethoxazole, nitrofurantoin, and fosfomycin. Although both nitrofurantoin and fosfomycin have shown efficacy against most urinary pathogens, no recent head-to-head comparisons have been reported. So, this study will be conducted to compare effectiveness of both drugs.",[50],"Urinary Tract Infections","NOT_YET_RECRUITING","2024-07-18",{"date":54,"type":55},"2024-07-24","ACTUAL",{"date":57,"type":44},"2025-01",{"date":59,"type":44},"2025-06",{"name":5,"class":6}]